<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30104343</article-id>
<article-id pub-id-type="pmc">6125809</article-id>
<article-id pub-id-type="publisher-id">0193-18</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0193-18.2018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Neurobiology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Favero</surname>
<given-names>Morgana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sotuyo</surname>
<given-names>Nathaniel P.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopez</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-1726-4769</contrib-id>
<name>
<surname>Kearney</surname>
<given-names>Jennifer A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-7404-735X</contrib-id>
<name>
<surname>Goldberg</surname>
<given-names>Ethan M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Division of Neurology, Department of Pediatrics, The Children's Hospital of Philadelphia, 19104 Philadelphia, Pennsylvania, </aff>
<aff id="aff2"><sup>2</sup>Department of Neuroscience, The Perelman School of Medicine at The University of Pennsylvania, 19104 Philadelphia, Pennsylvania, </aff>
<aff id="aff3"><sup>3</sup>College of Arts and Sciences, The University of Pennsylvania, 19104 Philadelphia, Pennsylvania, </aff>
<aff id="aff4"><sup>4</sup>Department of Pharmacology, Northwestern University Feinberg School of Medicine, 60611 Chicago, Illinois, and </aff>
<aff id="aff5"><sup>5</sup>Department of Neurology, The Perelman School of Medicine at The University of Pennsylvania, 19104 Philadelphia, Pennsylvania</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Ethan M. Goldberg,
<addr-line>Assistant Professor, Division of Neurology, The Children's Hospital of Philadelphia, Abramson Research Center, Room 502A, 3501 Civic Center Boulevard, Philadelphia, PA 19104.</addr-line><email>goldberge@email.chop.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: E.M.G. designed research; M.F., N.P.S., E.L., and E.M.G. performed research; J.A.K. contributed unpublished reagents/analytic tools; M.F., N.P.S., E.L., and E.M.G. analyzed data; E.M.G. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>5</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>3</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>38</volume>
<issue>36</issue>
<fpage>7912</fpage>
<lpage>7927</lpage>
<history>
<date date-type="received">
<day>3</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 the authors 0270-6474/18/387912-16$15.00/0</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns03618007912.pdf"></self-uri>
<abstract>
<p>Dravet syndrome is a severe, childhood-onset epilepsy largely due to heterozygous loss-of-function mutation of the gene <italic>SCN1A</italic>, which encodes the type 1 neuronal voltage-gated sodium (Na<sup>+</sup>) channel α subunit Nav1.1. Prior studies in mouse models of Dravet syndrome (<italic>Scn1a</italic><sup>+/−</sup> mice) indicate that, in cerebral cortex, Nav1.1 is predominantly expressed in GABAergic interneurons, in particular in parvalbumin-positive fast-spiking basket cell interneurons (PVINs). This has led to a model of Dravet syndrome pathogenesis in which Nav1.1 mutation leads to preferential dysfunction of interneurons, decreased synaptic inhibition, hyperexcitability, and epilepsy. However, such studies have been implemented at early developmental time points. Here, we performed electrophysiological recordings in acute brain slices prepared from male and female <italic>Scn1a</italic><sup>+/−</sup> mice as well as age-matched wild-type littermate controls and found that, later in development, the excitability of PVINs had normalized. Analysis of action potential waveforms indirectly suggests a reorganization of axonal Na<sup>+</sup> channels in PVINs from <italic>Scn1a</italic><sup>+/−</sup> mice, a finding supported by immunohistochemical data showing elongation of the axon initial segment. Our results imply that transient impairment of action potential generation by PVINs may contribute to the initial appearance of epilepsy, but is not the mechanism of ongoing, chronic epilepsy in Dravet syndrome.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Dravet syndrome is characterized by normal early development, temperature-sensitive seizures in infancy, progression to treatment-resistant epilepsy, developmental delay, autism, and sudden unexplained death due to mutation in <italic>SCN1A</italic> encoding the Na+ channel subunit Nav1.1. Prior work has revealed a preferential impact of Nav1.1 loss on the function of GABAergic inhibitory interneurons. However, such data derive exclusively from recordings of neurons in young <italic>Scn1a</italic><sup>+/−</sup> mice. Here, we show that impaired action potential generation observed in parvalbumin-positive fast-spiking interneurons (PVINs) in <italic>Scn1a</italic>+/− mice during early development has normalized by postnatal day 35. This work suggests that a transient impairment of PVINs contributes to epilepsy onset, but is not the mechanism of ongoing, chronic epilepsy in Dravet syndrome.</p>
</abstract>
<kwd-group>
<kwd>Dravet syndrome</kwd>
<kwd>epilepsy</kwd>
<kwd>fast-spiking interneurons</kwd>
<kwd>interneurons</kwd>
<kwd>Nav1.1</kwd>
<kwd>SCN1A</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>